These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30258192)

  • 1. Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women.
    Oltra SS; Peña-Chilet M; Vidal-Tomas V; Flower K; Martinez MT; Alonso E; Burgues O; Lluch A; Flanagan JM; Ribas G
    Sci Rep; 2018 Sep; 8(1):14373. PubMed ID: 30258192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceleration in the DNA methylation age in breast cancer tumours from very young women.
    Oltra SS; Peña-Chilet M; Flower K; Martinez MT; Alonso E; Burgues O; Lluch A; Flanagan JM; Ribas G
    Sci Rep; 2019 Oct; 9(1):14991. PubMed ID: 31628391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentially methylated microRNAs in prediagnostic samples of subjects who developed breast cancer in the European Prospective Investigation into Nutrition and Cancer (EPIC-Italy) cohort.
    Cordero F; Ferrero G; Polidoro S; Fiorito G; Campanella G; Sacerdote C; Mattiello A; Masala G; Agnoli C; Frasca G; Panico S; Palli D; Krogh V; Tumino R; Vineis P; Naccarati A
    Carcinogenesis; 2015 Oct; 36(10):1144-53. PubMed ID: 26168820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
    Zhang L; Yan DL; Yang F; Wang DD; Chen X; Wu JZ; Tang JH; Xia WJ
    Oncotarget; 2017 Jul; 8(28):45496-45505. PubMed ID: 28525377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer.
    Wee EJ; Peters K; Nair SS; Hulf T; Stein S; Wagner S; Bailey P; Lee SY; Qu WJ; Brewster B; French JD; Dobrovic A; Francis GD; Clark SJ; Brown MA
    Oncogene; 2012 Sep; 31(38):4182-95. PubMed ID: 22231446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
    Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale analysis of
    Croes L; Beyens M; Fransen E; Ibrahim J; Vanden Berghe W; Suls A; Peeters M; Pauwels P; Van Camp G; Op de Beeck K
    Clin Epigenetics; 2018; 10():51. PubMed ID: 29682089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
    Poli E; Zhang J; Nwachukwu C; Zheng Y; Adedokun B; Olopade OI; Han YJ
    PLoS One; 2015; 10(11):e0142224. PubMed ID: 26539832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation regulated microRNAs in human cervical cancer.
    Varghese VK; Shukla V; Kabekkodu SP; Pandey D; Satyamoorthy K
    Mol Carcinog; 2018 Mar; 57(3):370-382. PubMed ID: 29077234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential methylation and expression patterns of microRNAs in relation to breast cancer subtypes among American women of African and European ancestry.
    Gong Z; Chen J; Wang J; Liu S; Ambrosone CB; Higgins MJ
    PLoS One; 2021; 16(3):e0249229. PubMed ID: 33784351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of miRNA host gene promoter methylation in prostate cancer.
    Daniunaite K; Dubikaityte M; Gibas P; Bakavicius A; Rimantas Lazutka J; Ulys A; Jankevicius F; Jarmalaite S
    Hum Mol Genet; 2017 Jul; 26(13):2451-2461. PubMed ID: 28398479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors.
    Torres-Ferreira J; Ramalho-Carvalho J; Gomez A; Menezes FD; Freitas R; Oliveira J; Antunes L; Bento MJ; Esteller M; Henrique R; Jerónimo C
    Mol Cancer; 2017 Jan; 16(1):26. PubMed ID: 28143614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
    Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and DNA methylation alterations of seven cancer-associated 3p genes and their predicted regulator miRNAs (miR-129-2, miR-9-1) in breast and ovarian cancers.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Kazubskaya TP; Dmitriev AA; Braga EA
    Gene; 2016 Jan; 576(1 Pt 3):483-91. PubMed ID: 26519551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
    Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
    Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
    Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X
    Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer.
    Aure MR; Fleischer T; Bjørklund S; Ankill J; Castro-Mondragon JA; ; Børresen-Dale AL; Tost J; Sahlberg KK; Mathelier A; Tekpli X; Kristensen VN
    Genome Med; 2021 Apr; 13(1):72. PubMed ID: 33926515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Group of Hypermethylated miRNA Genes in Breast Cancer and Their Diagnostic Potential].
    Filippova EA; Loginov VI; Pronina IV; Khodyrev DS; Burdennyya AM; Kazubskaya TP; Braga EA
    Mol Biol (Mosk); 2019; 53(3):421-429. PubMed ID: 31184607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentially expressed microRNAs in postpartum breast cancer in Hispanic women.
    Muñoz-Rodríguez JL; Vrba L; Futscher BW; Hu C; Komenaka IK; Meza-Montenegro MM; Gutierrez-Millan LE; Daneri-Navarro A; Thompson PA; Martinez ME
    PLoS One; 2015; 10(4):e0124340. PubMed ID: 25875827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.